Skip to main content

Published locations for Biologics, TNF-inhibitors confer no excess cancer risks upon RA patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Biologics, TNF-inhibitors confer no excess cancer risks upon RA patients

User login

  • Reset your password
  • /content/biologics-tnf-inhibitors-confer-no-excess-cancer-risks-upon-ra-patients
  • /familypracticenews/article/141180/rheumatoid-arthritis/biologics-tnf-inhibitors-confer-no-excess
  • /internalmedicinenews/article/141180/rheumatoid-arthritis/biologics-tnf-inhibitors-confer-no-excess
  • /rheumatologynews/article/141180/rheumatoid-arthritis/biologics-tnf-inhibitors-confer-no-excess
  • /rheumatology/article/141180/rheumatoid-arthritis/biologics-tnf-inhibitors-confer-no-excess-cancer
  • /internalmedicine/article/141180/rheumatoid-arthritis/biologics-tnf-inhibitors-confer-no-excess
  • /familymedicine/article/141180/rheumatoid-arthritis/biologics-tnf-inhibitors-confer-no-excess-cancer